loading
전일 마감가:
$2.41
열려 있는:
$2.4
하루 거래량:
7,988
Relative Volume:
0.40
시가총액:
$26.93M
수익:
-
순이익/손실:
$-3.15M
주가수익비율:
-7.7982
EPS:
-0.3052
순현금흐름:
$-2.23M
1주 성능:
+2.01%
1개월 성능:
+5.78%
6개월 성능:
+1.71%
1년 성능:
+7.94%
1일 변동 폭
Value
$2.30
$2.40
1주일 범위
Value
$2.18
$2.50
52주 변동 폭
Value
$1.20
$4.0499

Cytomed Therapeutics Ltd Stock (GDTC) Company Profile

Name
명칭
Cytomed Therapeutics Ltd
Name
전화
-
Name
주소
-
Name
직원
34
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
GDTC's Discussions on Twitter

GDTC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GDTC
Cytomed Therapeutics Ltd
2.38 26.93M 0 -3.15M -2.23M -0.3052
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
503.50 126.09B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
568.91 64.01B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.51 36.63B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
257.19 30.64B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.77 27.24B 3.81B -644.79M -669.77M -6.24

Cytomed Therapeutics Ltd 주식(GDTC)의 최신 뉴스

pulisher
Apr 28, 2025

CytoMed 2024 Results: 39% Lower Losses as Biotech Advances Novel Cancer Cell Therapy Trial - Stock Titan

Apr 28, 2025
pulisher
Feb 27, 2025

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 06, 2025

CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders - Marketscreener.com

Feb 06, 2025
pulisher
Jan 09, 2025

SunAct Cancer Institute and CytoMed begin phase 2 trials for Gamma Delta T-cell therapy - Express Healthcare

Jan 09, 2025
pulisher
Jan 08, 2025

CytoMed Therapeutics (NASDAQ:GDTC) Shares Down 13.7% – Here’s What Happened - Defense World

Jan 08, 2025
pulisher
Jan 07, 2025

CytoMed and SunAct Collaborate on Cancer Immunotherapy Trials in India - Yahoo Finance

Jan 07, 2025
pulisher
Jan 07, 2025

CytoMed Therapeutics and SunAct to conduct solid tumour treatment trial in India - Yahoo Finance

Jan 07, 2025
pulisher
Jan 06, 2025

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor - Benzinga

Jan 06, 2025
pulisher
Jan 06, 2025

CytoMed Therapeutics Limited Signs Business & Research Collaboration Agreement with Sunact Cancer Institute Private Limited to Advance Use of Allogeneic Off-The-Shelf Gamma Delta T Cells for Treatment of Solid Cancers in Proposed Phase 2 Clinical Tr - Marketscreener.com

Jan 06, 2025
pulisher
Jan 06, 2025

CytoMed and SunAct partner for cancer immunotherapy trials - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial in - Marketscreener.com

Jan 06, 2025
pulisher
Jan 03, 2025

CytoMed Therapeutics Leads 3 US Penny Stocks To Consider - Simply Wall St

Jan 03, 2025
pulisher
Dec 11, 2024

CytoMed Therapeutics Limited Announces Resignation of Dr Tan Wee Kiat as Co-Chief Executive Officer, Effective December 31, 2024 - Marketscreener.com

Dec 11, 2024
pulisher
Dec 10, 2024

CytoMed Therapeutics Limited Announces Resignation of Dr Tan Wee Kiat as Director and Chief Operating Officer, Effective December 31, 2024 - Marketscreener.com

Dec 10, 2024
pulisher
Dec 05, 2024

CytoMed Therapeutics : Organisation and personnel changes Form 6 K - Marketscreener.com

Dec 05, 2024
pulisher
Dec 05, 2024

CytoMed Therapeutics And 2 Other US Penny Stocks To Watch - Simply Wall St

Dec 05, 2024
pulisher
Nov 20, 2024

CytoMed Therapeutics : Update on Clinical Milestone CytoMed Therapeutics Announces First Patient Dosed in its First in Human Phase I Clinical Trial of Allogeneic CAR Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematologica - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

CytoMed Therapeutics Limited Announces First Patient Dosed in Its First-In-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

Update on Clinical MilestoneCytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies - Yahoo Finance

Nov 20, 2024
pulisher
Oct 23, 2024

Discovering Penny Stocks On US Exchanges: 3 Picks Under $100M Market Cap - Simply Wall St

Oct 23, 2024
pulisher
Oct 17, 2024

Osteopore partners with NASDAQ-listed CytoMed to advance MSC-powered regeneration - Biotech Dispatch

Oct 17, 2024
pulisher
Oct 16, 2024

Osteopore Partners with CytoMed in Regenerative Medicine - TipRanks

Oct 16, 2024
pulisher
Oct 07, 2024

Cytomed Therapeutics announces NMRC co-funding support for ANGELICA trial - TipRanks

Oct 07, 2024
pulisher
Oct 07, 2024

CytoMed Launches Innovative CAR-T Cell Trial - TipRanks

Oct 07, 2024
pulisher
Oct 07, 2024

CytoMed begins clinical trial for innovative cancer therapy By Investing.com - Investing.com UK

Oct 07, 2024
pulisher
Oct 03, 2024

CytoMed Therapeutics completes cash acquisition of Cord - GlobeNewswire

Oct 03, 2024
pulisher
Sep 30, 2024

CytoMed Therapeutics Reports Six Months Ended June 30, 2024 - GlobeNewswire

Sep 30, 2024
pulisher
Aug 20, 2024

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewswire

Aug 20, 2024
pulisher
Jul 17, 2024

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers - GlobeNewswire

Jul 17, 2024
pulisher
Jun 14, 2024

Emergence of Cell and Gene Therapy Community in Singapore - BSA bureau

Jun 14, 2024
pulisher
Mar 20, 2024

Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration | Value Investing NewsInvestor powered stock market news - Financial Content

Mar 20, 2024
pulisher
Mar 04, 2024

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair - GlobeNewswire

Mar 04, 2024
pulisher
Jan 29, 2024

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology - Yahoo Finance

Jan 29, 2024
pulisher
Jan 23, 2024

GDTC Stock Price and Chart — NASDAQ:GDTC - TradingView

Jan 23, 2024
pulisher
Dec 05, 2023

Singapore-China collaboration to explore allogeneic gamma delta T cell technology for cancer treatment - BioSpectrum Asia

Dec 05, 2023
pulisher
Nov 17, 2023

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update - PR Newswire

Nov 17, 2023
pulisher
Aug 29, 2023

CytoMed Expands Research Collaboration into China After Entering Into MOU - StreetInsider

Aug 29, 2023
pulisher
Aug 15, 2023

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency - PR Newswire

Aug 15, 2023
pulisher
Aug 01, 2023

CytoMed Therapeutics Granted Patent in China for Licensed Allogeneic CAR-Gamma Delta T Cell Technology - Investing.com South Africa

Aug 01, 2023
pulisher
May 11, 2023

CytoMed Therapeutics to Ring Nasdaq Closing Bell - Stock Titan

May 11, 2023
pulisher
May 10, 2023

CytoMed and MD Anderson partner to use gdTc for cancer treatment - Pharmaceutical Technology

May 10, 2023
pulisher
Apr 18, 2023

Cytomed squeaks out $9.6M in a near-frozen IPO market - BioWorld MedTech

Apr 18, 2023
pulisher
Apr 17, 2023

Peter Choo-backed biomed firm CytoMed lists on Nasdaq - The Edge Singapore

Apr 17, 2023
pulisher
Apr 13, 2023

GDTCCytoMed Therapeutics Ltd Latest Stock News & Market Updates - Stock Titan

Apr 13, 2023
pulisher
Apr 13, 2023

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering - PR Newswire

Apr 13, 2023
pulisher
Feb 03, 2023

IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO (Pending:GDTC) - Seeking Alpha

Feb 03, 2023
pulisher
Mar 03, 2021

CytoMed Therapeutics (NASDAQ:GDTC) Stock Quotes, Forecast and News Summary - Benzinga

Mar 03, 2021
pulisher
Mar 01, 2019

Malaysia-Singapore Collaborates In The Field Of Clinical Research - BusinessToday

Mar 01, 2019
pulisher
Feb 26, 2019

Compulsory vaccination: MOH prepared to hear views from all - theSun

Feb 26, 2019
pulisher
Feb 05, 2019

Biotech & Pharma News, Stocks, FDA Decision, Clinical Trials - RTTNews

Feb 05, 2019

Cytomed Therapeutics Ltd (GDTC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.79
price up icon 0.78%
$71.40
price up icon 2.20%
$32.71
price up icon 0.52%
$23.62
price down icon 2.03%
$104.00
price up icon 0.00%
biotechnology ONC
$249.77
price up icon 0.12%
자본화:     |  볼륨(24시간):